Vivos Therapeutics reports 35% revenue increase in Q2 2026

🌐 Investing.com (CY) — 2026-08-14

Vivos Therapeutics announced a 35% increase in Q2 2026 revenue, indicating strong financial growth. The company continues to report solid performance metrics based on Investing.com updates from Cyprus.

Markets Deals Vivos Therapeutics Q2 revenue financial growth pharmaceuticals market performance

Read original source →

Quaest: 46% aprovam e 48% desaprovam governo Lula
Globo — 2026-08-14
Intra-Asia Container Index – 13 Aug
Hellenic Shipping News — 2026-08-14
China Thermal Coal Outlook: Domestic Supply Keeps Import Needs Contained
Hellenic Shipping News — 2026-08-14
Xeneta analyst insight – Middle East war impact spreads to long term market
Hellenic Shipping News — 2026-08-14
Bidding Announcement of 22830.6t Bulk Carrier “YONG DING HE”
Hellenic Shipping News — 2026-08-14
Drewry World Container Index
Hellenic Shipping News — 2026-08-14

Vivos Therapeutics reports 35% revenue increase in Q2 2026

AI Summary

Related Articles

Quaest: 46% aprovam e 48% desaprovam governo Lula

Intra-Asia Container Index – 13 Aug

China Thermal Coal Outlook: Domestic Supply Keeps Import Needs Contained

Xeneta analyst insight – Middle East war impact spreads to long term market

Bidding Announcement of 22830.6t Bulk Carrier “YONG DING HE”

Drewry World Container Index